These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30899576)

  • 21. Lassa Virus Reverse Genetics.
    Martínez-Sobrido L; Paessler S; de la Torre JC
    Methods Mol Biol; 2017; 1602():185-204. PubMed ID: 28508222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction and Immunological Evaluation of an Adenoviral Vector-Based Vaccine Candidate for Lassa Fever.
    Wang M; Li R; Li Y; Yu C; Chi X; Wu S; Liu S; Xu J; Chen W
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33804206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of Lassa virus in wild rodent feces: Implications for Lassa fever burden within households in the endemic region of Faranah, Guinea.
    Wood R; Bangura U; Mariën J; Douno M; Fichet-Calvet E
    One Health; 2021 Dec; 13():100317. PubMed ID: 34522759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Evaluation of Standard RT-PCR Assays and Commercial Real-Time RT-PCR Kits for Detection of Lassa Virus.
    Luo XL; Zhang XD; Li BJ; Qin T; Cao ZJ; Fan QJ; Yang J; Jin D; Lu S; Zheng YY; Xu XF; Pu J; Xu J
    Microbiol Spectr; 2023 Mar; 11(2):e0501122. PubMed ID: 36976009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lassa Virus Cell Entry via Dystroglycan Involves an Unusual Pathway of Macropinocytosis.
    Oppliger J; Torriani G; Herrador A; Kunz S
    J Virol; 2016 Jul; 90(14):6412-6429. PubMed ID: 27147735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs.
    Maruyama J; Mateer EJ; Manning JT; Sattler R; Seregin AV; Bukreyeva N; Jones FR; Balint JP; Gabitzsch ES; Huang C; Paessler S
    Vaccine; 2019 Oct; 37(45):6824-6831. PubMed ID: 31561999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding Immune Responses to Lassa Virus Infection and to Its Candidate Vaccines.
    Murphy H; Ly H
    Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an RT-LAMP assay for the detection of Lassa viruses in southeast and south-central Nigeria.
    Pemba CM; Kurosaki Y; Yoshikawa R; Oloniniyi OK; Urata S; Sueyoshi M; Zadeh VR; Nwafor I; Iroezindu MO; Ajayi NA; Chukwubike CM; Chika-Igwenyi NM; Ndu AC; Nwidi DU; Maehira Y; Unigwe US; Ojide CK; Onwe EO; Yasuda J
    J Virol Methods; 2019 Jul; 269():30-37. PubMed ID: 30974179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lassa virus diversity and feasibility for universal prophylactic vaccine.
    Lukashevich IS; Paessler S; de la Torre JC
    F1000Res; 2019; 8():. PubMed ID: 30774934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geographic distribution and genetic characterization of Lassa virus in sub-Saharan Mali.
    Safronetz D; Sogoba N; Lopez JE; Maiga O; Dahlstrom E; Zivcec M; Feldmann F; Haddock E; Fischer RJ; Anderson JM; Munster VJ; Branco L; Garry R; Porcella SF; Schwan TG; Feldmann H
    PLoS Negl Trop Dis; 2013; 7(12):e2582. PubMed ID: 24340119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lassa Fever Natural History and Clinical Management.
    Grant DS; Samuels RJ; Garry RF; Schieffelin JS
    Curr Top Microbiol Immunol; 2023; 440():165-192. PubMed ID: 37106159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of a protective intradermal DNA vaccine against lassa virus in cynomolgus macaques.
    Jiang J; Banglore P; Cashman KA; Schmaljohn CS; Schultheis K; Pugh H; Nguyen J; Humeau LM; Broderick KE; Ramos SJ
    Hum Vaccin Immunother; 2019; 15(9):2066-2074. PubMed ID: 31071008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever.
    Cross RW; Woolsey C; Prasad AN; Borisevich V; Agans KN; Deer DJ; Geisbert JB; Dobias NS; Fenton KA; Geisbert TW
    Cell Rep; 2022 Jul; 40(3):111094. PubMed ID: 35858566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuated Replication of Lassa Virus Vaccine Candidate ML29 in STAT-1
    Johnson DM; Jokinen JD; Lukashevich IS
    Pathogens; 2019 Jan; 8(1):. PubMed ID: 30650607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The search for animal models for Lassa fever vaccine development.
    Lukashevich IS
    Expert Rev Vaccines; 2013 Jan; 12(1):71-86. PubMed ID: 23256740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.
    Safronetz D; Rosenke K; Westover JB; Martellaro C; Okumura A; Furuta Y; Geisbert J; Saturday G; Komeno T; Geisbert TW; Feldmann H; Gowen BB
    Sci Rep; 2015 Oct; 5():14775. PubMed ID: 26456301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunobiology of Ebola and Lassa virus infections.
    Prescott JB; Marzi A; Safronetz D; Robertson SJ; Feldmann H; Best SM
    Nat Rev Immunol; 2017 Mar; 17(3):195-207. PubMed ID: 28111475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive Interactome Analysis Reveals that STT3B Is Required for N-Glycosylation of Lassa Virus Glycoprotein.
    Zhu S; Wan W; Zhang Y; Shang W; Pan X; Zhang LK; Xiao G
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inoculation route-dependent Lassa virus dissemination and shedding dynamics in the natural reservoir -
    Wozniak DM; Riesle-Sbarbaro SA; Kirchoff N; Hansen-Kant K; Wahlbrink A; Stern A; Lander A; Hartmann K; Krasemann S; Kurth A; Prescott J
    Emerg Microbes Infect; 2021 Dec; 10(1):2313-2325. PubMed ID: 34792436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Routine and pulse vaccination for Lassa virus could reduce high levels of endemic disease: A mathematical modelling study.
    Davies J; Lokuge K; Glass K
    Vaccine; 2019 Jun; 37(26):3451-3456. PubMed ID: 31088745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.